Piascledine


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 47.1%
Hypertension 7.7%
Osteoarthritis 7.2%
Depression 6.7%
Drug Use For Unknown Indication 4.8%
Pulmonary Embolism 2.9%
Hypercholesterolaemia 2.4%
Osteoporosis 2.4%
Arthritis 1.9%
Contraception 1.9%
Type 2 Diabetes Mellitus 1.9%
Arrhythmia 1.4%
Breast Cancer 1.4%
Bronchopneumopathy 1.4%
Chronic Obstructive Pulmonary Disease 1.4%
Cognitive Disorder 1.4%
Constipation 1.4%
Dermatosis 1.4%
Pain 1.4%
Phlebitis 1.4%
Thrombocytopenia 15.9%
Visual Acuity Reduced 11.4%
Jaundice 6.8%
Pain In Extremity 6.8%
Pancreatic Neoplasm 6.8%
Rash 6.8%
Bone Marrow Failure 4.5%
Dehydration 4.5%
Hyperkalaemia 4.5%
Weight Decreased 4.5%
Weight Increased 4.5%
Wound 4.5%
Dyspnoea 2.3%
General Physical Health Deterioration 2.3%
Hearing Impaired 2.3%
Insomnia 2.3%
Liver Function Test Abnormal 2.3%
Malaise 2.3%
Metabolic Acidosis 2.3%
Renal Failure Acute 2.3%
Concomitant
Product Used For Unknown Indication 34.8%
Drug Use For Unknown Indication 15.8%
Hypertension 8.7%
Hiv Infection 5.9%
Osteoarthritis 5.8%
Osteoporosis 4.8%
Premedication 3.0%
Depression 2.5%
Anaesthesia 2.3%
Pain 2.3%
Hepatitis C 2.1%
Anxiety 1.5%
Anaemia 1.4%
Hypercholesterolaemia 1.4%
Prophylaxis 1.4%
Breast Cancer 1.3%
Chronic Lymphocytic Leukaemia 1.3%
Epilepsy 1.3%
Hypothyroidism 1.3%
Postoperative Care 1.3%
Weight Decreased 17.5%
Renal Failure 9.3%
Death 7.2%
Vomiting 6.2%
Tendonitis 5.2%
Thrombocytopenia 5.2%
Hepatitis Cholestatic 4.1%
Jaundice 4.1%
Lipase Increased 4.1%
Pancreatitis 4.1%
Retinal Ischaemia 4.1%
Tremor 4.1%
Cytolytic Hepatitis 3.1%
Deep Vein Thrombosis 3.1%
Hypersensitivity 3.1%
International Normalised Ratio Increased 3.1%
Malaise 3.1%
Myocarditis 3.1%
Pancreatitis Acute 3.1%
Pulmonary Embolism 3.1%

Drug Data